share_log

Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $105-Report Released on 8th February 2024

Benzinga ·  Feb 9 17:02

Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $92 to $105.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment